- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Mercaptopurine is a drug used to treat gastrointestinal diseases, such as Crohn's disease and ulcerative colitis. It is an immunosuppressant, meaning it reduces the body's immune response, which can help reduce inflammation in the gastrointestinal tract. Mercaptopurine is usually taken orally, but can also be administered intravenously. It is often used in combination with other drugs, such as corticosteroids, to maximize its effectiveness.
Mercaptopurine is available in both generic and brand-name forms, and is sold by a variety of pharmaceutical companies. Some of the companies that produce and market mercaptopurine include AbbVie, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more